Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 24 Neoplasm Metastasis 9 Neoplasms by Site 2 Neoplasms 2 Breast Diseases 2 von Hippel-Lindau Disease 1 Unilateral Breast Neoplasms 1 Skin Diseases 1 Sarcoma 1 Recurrence 1 Locally Advanced (Inoperable) or Metastatic Breast Cancer 1 Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer 1 HR+/HER2- Breast Cancer 1 HER2+ Breast Cancer 1 Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer 1 Carcinoma, Renal Cell 1 Breast Neoplasm Female 1 Breast Cancer Recurrent 1 Advanced Breast Cancer 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Breast Cancer Recurrent × palbociclib × Clear all

NCT03820830 2026-04-09

POLAR

ETOP IBCSG Partners Foundation

Phase 3 Active not recruiting

Breast Cancer Recurrent

Data powered by HemOnc (CC BY 4.0) Colophon ⚡